BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 503252)

  • 1. Inhibition by cholinergic agonists of the prolactin release induced by morphine.
    Muraki T; Tokunaga Y; Nakadate T; Kato R
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Sep; 308(3):249-54. PubMed ID: 503252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for adrenergic mediation of cholinergic inhibition of prolactin release.
    Grandison L; Meites J
    Endocrinology; 1976 Sep; 99(3):775-9. PubMed ID: 954668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of morphine with the cholinergic system on prolactin release.
    Fanjul LF; Ruiz de Galarreta CM; Meites J
    Proc Soc Exp Biol Med; 1981 Apr; 166(4):542-5. PubMed ID: 7220547
    [No Abstract]   [Full Text] [Related]  

  • 4. Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin.
    Flores CM; Hulihan-Giblin BA; Hornby PJ; Lumpkin MD; Kellar KJ
    Neuroendocrinology; 1992 May; 55(5):519-28. PubMed ID: 1350068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholinergic agonists and antagonists on self-stimulation behavior in the rat.
    Newman LM
    J Comp Physiol Psychol; 1972 Jun; 79(3):394-413. PubMed ID: 5054476
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinergic modification of naloxone-induced jumping in morphine dependent mice.
    Brase DA; Tseng LF; Loh HH; Way EL
    Eur J Pharmacol; 1974 Apr; 26(1):1-8. PubMed ID: 4857603
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of opiate agonists on growth hormone and prolactin release in rats.
    Shaar CJ; Clemens JA
    Fed Proc; 1980 Jun; 39(8):2539-43. PubMed ID: 6247214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a cholinergic influence on catecholaminergic pathways terminating in the anterior and medial basal hypothalamus.
    Morgan WW; Pfeil KA
    Brain Res; 1979 Sep; 173(1):47-56. PubMed ID: 487084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
    Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
    Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine inhibits dopaminergic and cholinergic induced ejaculation in rats.
    Zarrindast MR; Mamanpush SM; Rashidy-Pour A
    Gen Pharmacol; 1994 Jul; 25(4):803-8. PubMed ID: 7958745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone blocks nicotine-induced prolactin release.
    Flores CM; Hulihan-Giblin BA; Kellar KJ
    Neuropharmacology; 1989 Nov; 28(11):1287-90. PubMed ID: 2594167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.
    Kaakkola S; Ahtee L
    Psychopharmacology (Berl); 1977 Mar; 52(1):7-15. PubMed ID: 403561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cholinergic and anticholinergic drugs and a partial cholinergic agonist on the development and expression of physical dependence on morphine in rat.
    Frederickson RC; Pinsky C
    J Pharmacol Exp Ther; 1975 Apr; 193(1):44-55. PubMed ID: 1169318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for cholinergic control of gonadotropin and prolactin secretion.
    Libertun C; McCann SM
    Proc Soc Exp Biol Med; 1974 Nov; 147(2):498-504. PubMed ID: 4612554
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of prolactin secretion by cholinergic drug.
    Grandison L; Gelato M; Meites J
    Proc Soc Exp Biol Med; 1974 Apr; 145(4):1236-9. PubMed ID: 4827734
    [No Abstract]   [Full Text] [Related]  

  • 17. Restraint stress decreases afternoon plasma prolactin levels in female rats. Influence of neural antagonists and agonists on restraint-induced changes in plasma prolactin and corticosterone.
    Gala RR; Haisenleder DJ
    Neuroendocrinology; 1986; 43(2):115-23. PubMed ID: 3724981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of bombesin on basal, alpha-methyl-p-tyrosine, haloperidol, morphine, bremazocine and stress-induced prolactin secretion.
    Buydens P; Govaerts J; Velkeniers B; Finné E; Vanhaelst L
    Life Sci; 1988; 43(21):1755-60. PubMed ID: 2904106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic agonist-antagonist interactions on neocortical and limbic EEG activation.
    Yamamoto KI; Domino EF
    Int J Neuropharmacol; 1967 Sep; 6(5):357-73. PubMed ID: 6069723
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlated cholinomimetic-stimulated beta-endorphin and prolactin release in humans.
    Risch SC; Janowsky DS; Siever LJ; Judd LJ; Rausch JL; Huey LY; Beckman KA; Cohen RM; Murphy DL
    Peptides; 1982; 3(3):319-22. PubMed ID: 6289276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.